Marshall Wace, LLP Agenus Inc Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $263,760 - $535,637	-202,893 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $476,798 - $704,038	202,893 New	202,893 $499,000
Q2 2020 Aug 13, 2020	SELL	$2.29 - $4.24 $128,329 - $237,605	-56,039 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $107,594 - $246,011	56,039 New	56,039 $137,000
Q3 2019 Nov 14, 2019	SELL	$2.17 - $3.14 $359,937 - $520,831	-165,870 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $419,491 - $504,053	165,807 Added 263185.72%	165,870 $498,000
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $158 - $234	63 New	63 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.